The Bulletin
Men's Weekly


.

YolTech Therapeutics Raises $45 Million in Series B Financing Led by AstraZeneca-CICC

  • Written by PR Newswire

SHANGHAI, Sept. 11, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage biotech company pioneering in vivo genome editing therapies, today announced the closing of its approximately $45 million Series B financing led by the AstraZeneca-CICC healthcare investment fund. The proceeds will support the advancement of YolTech's clinical programs...

The Bulletin Magazine

Packing a Life Into a Truck: What Interstate Moves Teach Us About Minimalism

Big Breastfeeding: Best Positions and Support for Nursing Moms

Why Choosing the Right Web Design in Katoomba Matters

The Pros and Cons of Buying vs. Leasing Commercial Real Estate

Fire Safety Myths That Put Your Workplace at Risk

10 Time-Saving Kitchen Hacks Every Home Cook Should Know

Common Types of OCD (Contamination, Checking, Intrusive Thoughts, etc.)

How Can Noise Reduction Ear Plugs Improve Sleep and Concentration

How Long After Stopping Breastfeeding Does Milk Production Stop? Here’s What You Should Know!

Discover the Unrivalled Relaxation of Luxury Cruises: Book Now!

Get Predictable IT Costs with Managed IT Support, Perth Experts

Struggling with Bidet Toilet Installation? Expert Tips to Solve Problems